The SAMe-TT2R2 Score Predicts Warfarin Control in an Australian Population With Atrial Fibrillation

Journal of Clinical Medicine
doi 10.3390/jcm8060882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Estimating an Icer With NOAC Versus Warfarin in Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation

American Journal of Kidney Diseases
Nephrology
2017English

A High HASBLED Score Identifies Poor Warfarin Control in Patients Treated for Non-Valvular Atrial Fibrillation in Australia and Singapore

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Analysis of Warfarin Usage and INR Control in Atrial Fibrillation: A Retrospective Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy